oseltamivir has been researched along with zithromax in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (3.33) | 29.6817 |
2010's | 9 (30.00) | 24.3611 |
2020's | 20 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Cao, B; Chen, YS; Gu, L; Li, XW; Liang, L; Liang, ZA; Lu, HZ; Lu, LH; Mao, Y; Wang, C; Wang, DY; Wang, J; Zhang, B; Zhang, SJ | 1 |
Cui, W; Feng, Y; Qi, Z; Ruan, J; Shao, Y; Tuszynski, JA; Wang, K | 1 |
Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kosai, K; Kurihara, S; Miyazaki, T; Morinaga, Y; Nakamura, S; Seki, M; Tashiro, T; Tsukamoto, M; Yanagihara, K | 1 |
Norris, A; Sandrock, CE | 1 |
Chan, MCW; Chan, PKS; Cheung, CSK; Choi, KW; Hui, DSC; Kwok, A; Lee, N; Leung, WS; Lui, GCY; Tam, WWS; Tsang, OTY; Wong, CK; Wong, RYK; Yeung, ESL; Yung, IMH | 1 |
Abed, Y; Boivin, G; Fage, C; Pizzorno, A; Rhéaume, C | 1 |
Liu, J; Long, X; Luo, H; Pan, X; Shen, F; Wang, S; Wu, J; Yao, L; Yuan, T | 1 |
Al-Khadouri, G; Hassan, KS | 1 |
Aljefri, D; Avedissian, SN; Cruce, CE; Liu, J; Martin, D; Pais, G; Postelnick, MJ; Rhodes, NJ; Scheetz, MH; Sutton, SH; Zembower, TR | 1 |
Alsultan, MT; Ishaqui, AA; Khan, AH; Khan, I; Naqvi, AA; Sulaiman, SAS | 1 |
George, K; Jacob, G; John, SB; Pai, S | 1 |
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM | 1 |
Albuquerque, BC; Alexandre, MAA; Baía-da-Silva, D; Balieiro, AAS; Bassat, Q; Borba, MGS; Brito, M; Brito-Sousa, JD; Croda, J; Daniel-Ribeiro, CT; Fontes, CJ; Guerra, MVF; Hajjar, LA; Lacerda, MVG; Melo, GC; Monteiro, WM; Mourão, MPG; Naveca, FG; Nogueira, ML; Pacheco, AGF; Pinto, RC; Romero, GAS; Sampaio, VS; Santos, JDO; Schwarzbold, A; Siqueira, AM; Val, FFA; Xavier, MS | 1 |
Aydın, GÇ; Azap, A; Dursun, B; Öztürk, HH; Ürün, Y; Utkan, G; Yazgan, SC; Yekedüz, E | 1 |
Çapar, G; Köse, M; Medetalibeyoğlu, A; Şenkal, N; Tükek, T | 1 |
Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N | 1 |
Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A | 1 |
Akram, J; Azhar, S; Khan, KS; Latif, W; Shahzad, M | 1 |
Esam, Z | 1 |
Grundmark, B; Vidlin, SH; Watson, S; Zekarias, A | 1 |
Mamishi, S; Navaeian, A; Shabanian, R | 1 |
Aytekin, S; Aytekin, V; Çelik, HG; Ergönül, Ö; Kapmaz, M; Keske, Ş; Özyıldırım, A; Şahin, ŞT; Şener, Ü; Tekbaş, M | 1 |
Akat, H; Laloglu, F; Orbak, Z | 1 |
Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M | 1 |
Arouche, TDS; Costa, FLP; Filho, TSA; Júnior, RNC; Martins, AY; Neto, AMJC; Ramalho, TC | 1 |
Baeza-Flores, GDC; Denis-García, CA; Flores-Barrientos, OI; Gonzalez-Castro, TB; Guzmán-Priego, CG; Juárez-Rojop, IE; López-Brito, CR; Narváez-Osorio, V; Nolasco-Rosales, GA; Pérez-García, A; Ruíz-Quiñonez, JA; Tovilla-Zarate, CA | 1 |
Cahyadi, A; Henrina, J; Pusparani, A | 1 |
Arabi, M; Bitar, F; Eid, AH; Fakhri, G; Younis, NK; Zareef, RO | 1 |
5 review(s) available for oseltamivir and zithromax
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Infection in severe asthma exacerbations and critical asthma syndrome.
Topics: Animals; Asthma; Azithromycin; Bacterial Infections; Ceftriaxone; Coinfection; Critical Illness; Disease Progression; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Seasons; Syndrome | 2015 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment | 2020 |
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever; Humans; Hydroxychloroquine; Levetiracetam; Male; Middle Aged; Myalgia; Opsoclonus-Myoclonus Syndrome; Oseltamivir; SARS-CoV-2; Valproic Acid | 2021 |
COVID-19: potential therapeutics for pediatric patients.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Child; COVID-19 Drug Treatment; Dexamethasone; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Oseltamivir; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
4 trial(s) available for oseltamivir and zithromax
Article | Year |
---|---|
Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Cytokines; Drug Therapy, Combination; Female; Humans; Inflammation Mediators; Influenza, Human; Male; Middle Aged; Oseltamivir; Treatment Outcome; Young Adult | 2014 |
Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiviral Agents; Azithromycin; Cytokines; Female; Hospitalization; Humans; Influenza, Human; Longitudinal Studies; Macrolides; Male; Middle Aged; Oseltamivir; Plasma; Severity of Illness Index; Treatment Outcome; Viral Load | 2017 |
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Brazil; Chloroquine; Coronavirus Infections; COVID-19; Disease Outbreaks; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tertiary Care Centers | 2020 |
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A struc
Topics: Azithromycin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2 | 2020 |
21 other study(ies) available for oseltamivir and zithromax
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Child; Child, Preschool; China; Disease Outbreaks; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Logistic Models; Lymphopenia; Male; Middle Aged; Ofloxacin; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Time Factors; Virus Shedding; Young Adult | 2009 |
The molecular mechanism of action of the CR6261-Azichromycin combination found through computational analysis.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Antibody Specificity; Antiviral Agents; Azithromycin; Drug Interactions; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Influenza A virus; Models, Molecular; Molecular Sequence Data; Oseltamivir; Protein Conformation | 2012 |
The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
Topics: Animals; Antiviral Agents; Azithromycin; Drug Therapy, Combination; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Injections, Intraperitoneal; Lung; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Viral Load | 2017 |
Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Coinfection; Female; Fluoroquinolones; Humans; Immunoglobulins; Influenza A Virus, H7N9 Subtype; Influenza, Human; Methylprednisolone; Moxifloxacin; Mycoplasma pneumoniae; Oseltamivir; Pneumonia, Mycoplasma | 2018 |
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Disease Progression; Drainage; Female; Humans; Mycoplasma pneumoniae; Oman; Oseltamivir; Pleural Effusion; Pneumonia, Mycoplasma; Young Adult | 2018 |
Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR).
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Humans; Inappropriate Prescribing; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Oseltamivir; Retrospective Studies; Seasons; Staphylococcal Infections | 2019 |
Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief.
Topics: Antiviral Agents; Azithromycin; Cohort Studies; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Length of Stay; Male; Middle Aged; Oseltamivir; Retrospective Studies; Treatment Outcome | 2020 |
Pneumonia with synpneumonic effusion and bacteraemia:
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Biomarkers; Ceftriaxone; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Male; Oseltamivir; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus | 2020 |
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
Topics: Aged; Antineoplastic Agents, Immunological; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Lung Neoplasms; Melanoma; Multiple Chronic Conditions; Nivolumab; Oseltamivir; Pandemics; Pneumonia, Viral; Programmed Cell Death 1 Receptor; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Female; Fever; Health Personnel; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Lung; Male; Middle Aged; Myalgia; Oseltamivir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Travel; Turkey; Young Adult | 2020 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin | 2020 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
Protective potential of expectorants against COVID-19.
Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dioxolanes; Expectorants; Humans; Medicine, Chinese Traditional; Mucus; Oseltamivir; Pandemics; Pneumonia, Viral; Povidone; SARS-CoV-2 | 2020 |
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Chemical and Drug Induced Liver Injury; Chloroquine; COVID-19 Drug Treatment; Databases, Pharmaceutical; Diarrhea; Drug Combinations; Drug Eruptions; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Nausea; Oseltamivir; Ritonavir; Sex Distribution; Sex Factors; Vomiting | 2020 |
Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Aortic Aneurysm; Aortic Dissection; Aortic Stenosis, Supravalvular; Aortitis; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Fatal Outcome; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Male; Methylprednisolone; Oseltamivir; Recurrence; Ritonavir; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Williams Syndrome | 2021 |
Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
Topics: Adult; Aged; Aged, 80 and over; Azithromycin; COVID-19 Drug Treatment; Electrocardiography; Female; Humans; Hydroxychloroquine; Influenza, Human; Long QT Syndrome; Male; Middle Aged; Oseltamivir; SARS-CoV-2 | 2021 |
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed | 2021 |
Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
Topics: Azithromycin; Coronavirus 3C Proteases; COVID-19; Heparin; Humans; Ivermectin; Lopinavir; Molecular Docking Simulation; Oseltamivir; Ritonavir; SARS-CoV-2 | 2021 |
Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 1; Female; Hospital Mortality; Hospitals; Humans; Hydroxychloroquine; Length of Stay; Male; Mexico; Middle Aged; Obesity; Oseltamivir; Retrospective Studies; SARS-CoV-2; Sex Factors | 2021 |
Co-infection of COVID-19 and recurrent malaria.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Humans; Indonesia; Malaria; Male; Oseltamivir; Recurrence; SARS-CoV-2; Young Adult | 2021 |